BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ohira M, Toyokawa T, Sakurai K, Kubo N, Tanaka H, Muguruma K, Yashiro M, Onoda N, Hirakawa K. Current status in remnant gastric cancer after distal gastrectomy. World J Gastroenterol 2016; 22(8): 2424-2433 [PMID: 26937131 DOI: 10.3748/wjg.v22.i8.2424] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen W, Zhang G, Dong Z, Liu L, Wang Y, Chen X, Zhang J, Wang C. Cardia Gastric Cancer in the Gastric Pouch 5 Years after Gastric Bypass: A Case Report. OBES SURG 2020;30:2021-5. [DOI: 10.1007/s11695-019-04336-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ma F, Ma Y, Cui L, Zhao X, Wang B, Xue L, Wang H, Tian Y. Development and characterization of a mouse model of duodenogastric reflux. Life Sci 2020;260:118412. [PMID: 32926924 DOI: 10.1016/j.lfs.2020.118412] [Reference Citation Analysis]
3 Sugimoto K, Ito T, Hulbert A, Chen C, Orita H, Maeda M, Moro H, Fukagawa T, Ushijima T, Katai H, Wada R, Sato K, Sakamoto K, Yu W, Considine M, Cope L, Brock MV. DNA methylation genome-wide analysis in remnant and primary gastric cancers. Gastric Cancer 2019;22:1109-20. [PMID: 30863929 DOI: 10.1007/s10120-019-00949-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lee Y, Lee CM, Park S, Kim JH, Park SH. Comparison of the Clinical Outcomes Between Isoperistaltic and Antiperistaltic Anastomoses After Laparoscopic Distal Gastrectomy for Patients With Gastric Cancer. Front Oncol 2020;10:1237. [PMID: 32850372 DOI: 10.3389/fonc.2020.01237] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kinami S, Nakamura N, Miyashita T, Kitakata H, Fushida S, Fujimura T, Iida Y, Inaki N, Ito T, Takamura H. Life prognosis of sentinel node navigation surgery for early-stage gastric cancer: Outcome of lymphatic basin dissection. World J Gastroenterol 2021;27:8010-30. [PMID: 35046627 DOI: 10.3748/wjg.v27.i46.8010] [Reference Citation Analysis]
6 Oh SE, An JY, Choi MG, Lee JH, Sohn TS, Bae JM. Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging. Eur J Surg Oncol 2020;46:2236-42. [PMID: 32788098 DOI: 10.1016/j.ejso.2020.06.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ramos MFKP, Pereira MA, de Castria TB, Ribeiro RRE, Cardili L, de Mello ES, Zilberstein B, Ribeiro-Júnior U, Cecconello I. Remnant gastric cancer: a neglected group with high potential for immunotherapy. J Cancer Res Clin Oncol 2020;146:3373-83. [PMID: 32671505 DOI: 10.1007/s00432-020-03322-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ramos MFKP, Pereira MA, Cardili L, de Mello ES, Ribeiro U Jr, Zilberstein B, Cecconello I. Expression profiles of gastric cancer molecular subtypes in remnant tumors. World J Gastrointest Oncol 2021;13:265-78. [PMID: 33889278 DOI: 10.4251/wjgo.v13.i4.265] [Reference Citation Analysis]
9 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kiyokawa T, Fukagawa T, Kaneshiro S, Igarashi Y, Soeda N, Kumata Y, Horikawa M, Sasajima Y, Matsuda K, Fukushima R. Accuracy of preoperative staging of gastric stump cancer. Jpn J Clin Oncol 2022:hyac031. [PMID: 35296901 DOI: 10.1093/jjco/hyac031] [Reference Citation Analysis]
11 Han ES, Seo HS, Kim JH, Lee HH. Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer. Ann Surg Oncol 2020;27:4216-24. [PMID: 32372310 DOI: 10.1245/s10434-020-08517-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Huang F, Wang BR, Wu YQ, Wang FC, Zhang J, Wang YG. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer. World J Gastroenterol 2016; 22(35): 7999-8009 [PMID: 27672294 DOI: 10.3748/wjg.v22.i35.7999] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
13 Zhang LY, Zhang J, Li D, Liu Y, Zhang DL, Liu CF, Wang N, Wu SR, Lu WQ, Guo JZ, Shi YQ. Bile reflux is an independent risk factor for precancerous gastric lesions and gastric cancer: An observational cross-sectional study. J Dig Dis 2021;22:282-90. [PMID: 33793080 DOI: 10.1111/1751-2980.12986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Song XH, Liu K, Sun LF, Chen XL, Zhao LY, Zhang WH, Chen XZ, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Clinicopathological characteristics and prognostic factors of remnant gastric cancer: A single-center retrospective analysis of 90 patients. Int J Surg. 2018;51:97-103. [PMID: 29367041 DOI: 10.1016/j.ijsu.2018.01.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Iranmanesh P, Manisundaran NV, Bajwa KS, Thosani NC, Felinski MM, Wilson EB, Shah SK. Management of Acute Gastric Remnant Complications After Roux-en-Y Gastric Bypass: a Single-Center Case Series. Obes Surg 2020;30:2637-41. [PMID: 32162207 DOI: 10.1007/s11695-020-04537-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
16 Çiçek E, Zengin A, Güneş Ö, Sümer F, Kayaalp C. Laparoscopic gastrectomy in remnant gastric cancer. Turk J Surg 2021;37:59-62. [PMID: 34585095 DOI: 10.47717/turkjsurg.2021.5123] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Xie MZ, He ZM, Huang FJ, Zhou XQ, Wu ZZ. Comparative study of saliva peptide signatures between gastric carcinoma and chronic gastritis. Shijie Huaren Xiaohua Zazhi 2016; 24(13): 1976-1983 [DOI: 10.11569/wcjd.v24.i13.1976] [Reference Citation Analysis]
18 Park YE, Kim SW. Clinicopathologic features of remnant gastric cancer after curative distal gastrectomy according to previous reconstruction method: a retrospective cohort study. World J Surg Oncol 2019;17:203. [PMID: 31785616 DOI: 10.1186/s12957-019-1740-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Han WH, Eom BW, Yoon HM, Kim YW, Kook MC, Ryu KW. The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy. Cancers (Basel) 2020;12:E2847. [PMID: 33023082 DOI: 10.3390/cancers12102847] [Reference Citation Analysis]
20 Chowdappa R, Tiwari AR, Ranganath N, Kumar RV. Is there difference between anastomotic site and remnant stump carcinoma in gastric stump cancers? J Gastrointest Oncol. 2019;10:307-313. [PMID: 31032099 DOI: 10.21037/jgo.2018.12.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
21 Kojima K, Minatani N, Ushiku H, Ishii S, Tanaka T, Yokoi K, Nishizawa N, Ooizumi Y, Igarashi K, Hosoda K, Moriya H, Mieno H, Watanabe M, Yamashita K. Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin. Oncotarget. 2019;10:2423-2434. [PMID: 31069006 DOI: 10.18632/oncotarget.26814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Lage J, Uedo N, Dinis-Ribeiro M, Yao K. Surveillance of patients with gastric precancerous conditions. Best Pract Res Clin Gastroenterol. 2016;30:913-922. [PMID: 27938786 DOI: 10.1016/j.bpg.2016.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
23 Li ZY, Liu JJ, Yu PW, Zhao YL, Shi Y, Luo ZY, Wu B, Wang JJ, Qian F. Robotic total gastrectomy for carcinoma in the remnant stomach: a comparison with laparoscopic total gastrectomy. Gastroenterol Rep (Oxf) 2021;9:583-8. [PMID: 34925855 DOI: 10.1093/gastro/goab021] [Reference Citation Analysis]
24 Zhang N, Fei Q, Gu J, Yin L, He X. Progress of preoperative and postoperative radiotherapy in gastric cancer. World J Surg Oncol 2018;16:187. [PMID: 30213266 DOI: 10.1186/s12957-018-1490-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
25 Camacho-Gomez SM, Bernieh A, Saad AG, Tipnis NA. Non-Helicobacter pylori Gastric Intestinal Metaplasia in Children: A Series of Cases and Review of the Literature. Case Rep Gastrointest Med 2018;2018:5930415. [PMID: 29850294 DOI: 10.1155/2018/5930415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Ramos MFKP, Pereira MA, Dias AR, Dantas ACB, Szor DJ, Ribeiro U Jr, Zilberstein B, Cecconello I. Remnant gastric cancer: An ordinary primary adenocarcinoma or a tumor with its own pattern? World J Gastrointest Surg 2021;13:366-78. [PMID: 33968303 DOI: 10.4240/wjgs.v13.i4.366] [Reference Citation Analysis]
27 Alhossaini RM, Altamran AA, Cho M, Roh CK, Seo WJ, Choi S, Son T, Kim H, Hyung WJ. Lower rate of conversion using robotic-assisted surgery compared to laparoscopy in completion total gastrectomy for remnant gastric cancer. Surg Endosc 2020;34:847-52. [DOI: 10.1007/s00464-019-06838-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
28 Chen W, Wang Y, Zhu J, Wang C, Dong Z. Esophagogastric Cancer After Sleeve Gastrectomy: A Systematic Review of Case Reports. Cancer Manag Res 2021;13:3327-34. [PMID: 33883944 DOI: 10.2147/CMAR.S303590] [Reference Citation Analysis]
29 Dhir M. Gastric Remnant Cancer: Is it different From Primary Gastric Cancer? Insights Into a Unique Clinical Entity. Ann Surg Oncol 2020;27:4079-81. [PMID: 32524462 DOI: 10.1245/s10434-020-08690-5] [Reference Citation Analysis]
30 Kinami S, Aizawa M, Yamashita H, Kumagai K, Kamiya S, Toda M, Takahata T, Fujisaki M, Miyamoto H, Kusanagi H, Kobayashi K, Washio M, Hosoda K, Kosaka T. The incidences of metachronous multiple gastric cancer after various types of gastrectomy: analysis of data from a nationwide Japanese survey. Gastric Cancer 2021;24:22-30. [PMID: 32780194 DOI: 10.1007/s10120-020-01104-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Braghetto I, Csendes A. SINGLE ANASTOMOSIS GASTRIC BYPASS (ONE ANASTOMOSIS GASTRIC BYPASS OR MINI GASTRIC BYPASS): THE EXPERIENCE WITH BILLROTH II MUST BE CONSIDERED AND IS A CHALLENGE FOR THE NEXT YEARS. Arq Bras Cir Dig 2017;30:267-71. [PMID: 29340552 DOI: 10.1590/0102-6720201700040010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
32 Ramos MFKP, Pereira MCM, Oliveira YS, Pereira MA, Barchi LC, Dias AR, Zilberstein B, Ribeiro Junior U, Cecconello I. Surgical results of remnant gastric cancer treatment. Rev Col Bras Cir 2020;47:e20202703. [PMID: 33263654 DOI: 10.1590/0100-6991e-20202703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Choi YJ, Kim DH, Han HS, Han JH, Son SM, Kim DS, Yun HY. Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis. World J Gastroenterol 2018; 24(1): 150-156 [PMID: 29358891 DOI: 10.3748/wjg.v24.i1.150] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
34 Urakawa S, Yamasaki M, Makino T, Kurokawa Y, Yamamoto K, Goto K, Haruna M, Hirata M, Morimoto-Okazawa A, Kawashima A, Iwahori K, Mizushima T, Sato E, Mori M, Doki Y, Wada H. The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy. Cancer Immunol Immunother 2021;70:443-52. [PMID: 32803278 DOI: 10.1007/s00262-020-02696-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kaihara M, Matsuda S, Booka E, Saida F, Takashima J, Kasai H, Mihara K, Nagashima A, Egawa T. Laparoscopic completion gastrectomy in elderly patients with remnant gastric cancer: a case series. Surg Case Rep. 2019;5:63. [PMID: 31001749 DOI: 10.1186/s40792-019-0610-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Shi J, Jiang Y, Zhao Y. Promising in vitro and in vivo inhibition of multidrug-resistant Helicobacter pylori by linezolid and novel oxazolidinone analogues. Journal of Global Antimicrobial Resistance 2016;7:106-9. [DOI: 10.1016/j.jgar.2016.07.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]